Icon

RISPERDAL (nda020272)- (0.25MG,0.5MG,1MG,2MG,3MG,4MG,5MG)

RISPERIDONE JANSSEN PHARMS
0.25MG,0.5MG,1MG,2MG,3MG,4MG,5MG
Yes No
2010-Apr-27 Expired
None None
None No
RISPERDAL® is an atypical antipsychotic indicated for: • Treatment of schizophrenia • As monotherapy or adjunctive therapy with lithium or valproate, for the treatment of acute manic or mixed episodes associated with Bipolar I Disorder • Treatment of irritability associated with autistic disorder.
13 0 8
Total Other Developers 1
Drugs with Suitability No
0.25MG ** ** - - 4
0.5MG ** ** - - 5
1MG ** ** - - 5
2MG ** ** - - 5
3MG ** ** - - 5
4MG ** ** - - 5
5MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 5
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ** ****** **** *** **. *****'* ************ ******* *********** ****** **. **, ** ****, ** **** & ** ****, ********** ******* *** ******, *******-********** ********,, *******-**********, ********* ******, ***** (***) ***
****** ********* ********* ********* *************** *******, ***. *********** ** ******* *****, *** ***** ******, *******, *** **** (**) *****, ****** ****** (***) ***
****** ***** ****** *** *** ***** ************ ******* *********** ****** **. ***, *** *** ***, ******* ***** *. *. **. ** *******-*******, ******-****** *********, *********, ******* ******, ***** (***) ***
****** ***** ****** *** *** ***** ************ ******* *********** ******* ****** *****, *.*. *****, ******-********, *****, ******** ******* ******, ***** (***) ***
****** ****** ****** *************** ** *** ****, *** *********** ** ********** **, **********, *** **** (**) *****-****, ****** ****** (***) ***
****** ****** ****** ******* (******* *****-*) *********** *********** ******* ********, ********, ******, ********, ***********, *******, ****, ********** (***) ***
****** ******* ****** ******* *************** ******* *********** **** **. */*** ** ***, ***** *** ****-**, ****** *****, ****. *******, *******, ******* ******, ***** (***) ***
****** ******* ****** ******* *************** ******* *********** *********-******* *******, ******, ******-****, ****. *******, ******, ******* ******, ***** (***) ***
****** ****** ****** *** ****** ****** ******* *********** **** **. *-*** /* ***** *** - **** **, *******, ******* ******, ***** (***) ***
****** ****** ****** *** ****** ****** ******* *********** *-*\*\*, **** ****, *******, *********** *************, *********** ******, ***** (***) ***
****** ****** ****** *** ******* ****** *************** *** *********** * ********* ***, *******, *******, ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.